Topics

Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Arthroplasty, Replacement,Venous Thromboembolism, Date of authorisation: 30/09/2008, Revision: 29, Status: Authorised

07:00 EDT 14 Aug 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Arthroplasty, Replacement,Venous Thromboembolism, Date of authorisation: 30/09/2008, Revision: 29, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Arthroplasty, Replacement,Venous Thromboembolism, Date of authorisation: 30/09/2008, Revision: 29, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Xarelto, rivaroxaban, Arthroplasty, Replacement,Venous Thromboembolism, Date of authorisation: 30/09/2008, Revision: 29, Status: Authorised"

Quick Search

Relevant Topic

Orthopedics
Arthroplasty Joint Disorders Orthopedics Spinal Cord Disorders Orthopedics is the science or practice of correcting deformities caused by disease or damage to the bones and joints of the skeleton. This specialized branch of surgery may ...